THE CODI Co.,LTD.
Research THE CODI Co.,LTD. (224060.KQ) on Bullrun: market cap KRW 17.43B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker224060.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorTechnology
- IndustrySemiconductor Equipment & Materials
- CurrencyKRW
- Market capKRW 17.43B
- Financial periodQ2 2026
- RevenueKRW 5.99B
- Net income-KRW 342.76M
- Free cash flow-KRW 184.84M
- Gross margin17.3%
Valuation Snapshot
latest market cap is KRW 17.43B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 17.43B | n/a | n/a | n/a |
Dividend history
About THE CODI Co.,LTD.
THE CODI Co.,LTD. manufactures and sells semiconductor and display equipment, exposure equipment, and bio-healthcare products. It develops therapeutic agents for various diseases, such as Zika/MERS, glaucoma, non-alcoholic fatty liver, and chronic kidney diseases, as well as immunotherapy to treat cancer and inflammatory diseases. THE CODI Co.,LTD. was formerly known as CODI-M Co., LTD. and changed its name to THE CODI Co.,LTD. in November 2022. THE CODI Co.,LTD.
Related stock research
Other Technology stocks
Frequently asked questions
What is THE CODI Co.,LTD.'s market cap?
THE CODI Co.,LTD.'s market capitalization is KRW 17.43B.
What does THE CODI Co.,LTD. do?
THE CODI Co.,LTD. manufactures and sells semiconductor and display equipment, exposure equipment, and bio-healthcare products. It develops therapeutic agents for various diseases, such as Zika/MERS, glaucoma, non-alcoholic fatty liver, and chronic kidney diseases, as well as immunotherapy to treat cancer and inflammatory diseases. THE CODI Co.,LTD. was formerly known as CODI-M Co., LTD. and changed its name to THE CODI Co.,LTD. in November 2022. THE CODI Co.,LTD. was incorporated in 1999 and is based in Cheonan-si, South Korea.